Together with NANOG, SOX2, and other transcription regulators, Oct4 activated both protein-coding genes and non-coding RNAs necessary for pluripotency which correlated with cell fate determination, proliferation, metastasis, drug resistance and invaded from apoptosis in cancer cells [19, 20]. The gene discussed is NANOG; the disease is cancer.